The B.1.617 variant is a COVID-19 variant that was first detected in India and was classified as a variant of concern by The World Health Organization (WHO) on 10 May 2021. Variants of concern show evidence of being more transmissible, causing more severe diseases or even reducing the effectiveness of treatments or vaccines. As a precaution, several vaccine makers are already developing booster shots to potentially target these COVID-19 variants.
In the latest health advisory released by Raffles Medical Group, Dr Michael Wong, Deputy Medical Director of Raffles Medical Group, provided his medical take on the B1.617 strain together with his expert opinion on whether the vaccination is able to protect you against such variants.
Download our health advisory below to find out more.
Resource Downloads
Key Takeaways
- Summary Point 1
- Summary Point 2
- Summary Point 3
Frequently Asked Questions
Get up to $5,000 hospitalisation coverage for COVID-19 side effects today.
If you find this information useful, do share this article with your family and friends to keep them up-to-date on COVID-19 vaccine news.
For more health tips and updates, Follow us on Facebook or Instagram.
You can also check out our other blog articles here!
